Product Recalls in Alabama

Product recalls affecting Alabama — including food, drugs, consumer products, medical devices, and vehicles distributed to Alabama. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,642 recalls have been distributed to Alabama in the last 12 months.

50,591 total recalls
2,642 in last 12 months

Showing 73017320 of 13,413 recalls

DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Stanozolol USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Sumatriptan Succinate USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Leucovorin Calcium USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Diclofenac Sodium USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Liothyronine Sodium USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Gabapentin USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Levothyroxine Sodium USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Medroxyprogesterone Acetate USP (Micronized) for prescription compounding...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Pentoxifylline USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Flurbiprofen USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Vancomycin HCl USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Naltrexone HCl USP (Dihydrate) for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Sumatriptan USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Levofloxacin Hemihydrate USP for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Clindamycin Phosphate USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Testosterone (Soy) (Micronized) USP for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Testosterone Enanthate USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Estrone USP for prescription compounding Recalled by American Pharmaceutical...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Lincomycin HCl USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Hydroxyprogesterone Caproate USP for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund